Financial Disclosure by Clinical Investigators

United States · Last verified: 2026-09-08

Number

21 CFR 54

Type

Regulation

Issuer

U.S. FDA

Status

in_force

Authority

FDA / CDRH

What this covers

临床研究者财务披露：申办者在 PMA、510(k) 等上市前申请中提交临床研究者财务利益信息的范围、认证与披露表要求，以及 FDA 的处理方式。

Source: U.S. Food and Drug Administration (public domain)